Literature DB >> 9305809

Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative.

M A Pozo1, E A Balazs, C Belmonte.   

Abstract

Hyaluronan (sodium hyaluronate) is a glycosaminoglycan that is present in all joint tissues. Painful arthritic joints have been characterized by hyaluronan of reduced elastoviscosity. The purpose of this investigation was to determine whether hyaluronan has an influence on joint nociceptor sensitivity and whether restoration of elastoviscosity would decrease nerve responses from nociceptive afferent fibers in arthritic joints. Nerve impulse activity was recorded from nociceptive afferent fibers of the medial articular nerve in anesthetized cats. An acute experimental arthritis was produced by intra-articular injection of kaolin and carrageenan. This caused, within 3 h, the development of ongoing nerve activity and enhancement of nerve impulse responses to passive movements in the normal range of the joint. Intra-articular injection of an elastoviscous solution of hylan, a hyaluronan derivative, significantly reduced both the ongoing activity and the movement-evoked responses in 1-2 h. This effect was not obtained when a nonelastoviscous solution of hylan was injected into the inflamed joint. The results indicate that intra-articularly injected elastoviscous solutions of hylan reduced nociceptive activity in inflamed joints through an elastoviscous, rheological effect on nociceptive afferent fibers through the intercellular matrix in which these fibers are embedded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305809     DOI: 10.1007/pl00005742

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  33 in total

1.  TRPV1 channel modulation by hyaluronan reduces pain.

Authors:  Elvira de la Peña; Ana Gomis; Antonio Ferrer-Montiel; Carlos Belmonte
Journal:  Channels (Austin)       Date:  2015-10-30       Impact factor: 2.581

Review 2.  Anatomy and pathophysiology of the sacroiliac joint.

Authors:  O Calvillo; I Skaribas; J Turnipseed
Journal:  Curr Rev Pain       Date:  2000

3.  Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression.

Authors:  P A Band; J Heeter; H-G Wisniewski; V Liublinska; C W Pattanayak; R J Karia; T Stabler; E A Balazs; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2014-10-07       Impact factor: 6.576

4.  Comparison of four different intra-articular injection sites in the knee: a cadaver study.

Authors:  Cem Esenyel; Mehmet Demirhan; Meltem Esenyel; Mesut Sonmez; Sinan Kahraman; Berna Senel; Taskin Ozdes
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-12-06       Impact factor: 4.342

5.  Managing intrinsic pro-degradatory mechanical and cellular cycles in the development of osteochondral lesions.

Authors:  Seok Jung Kim; Asode Ananthram Shetty; Saif Ahmed; Neha Shetty; Sang Heon Lee
Journal:  Ann Transl Med       Date:  2019-09

Review 6.  Hyaluronic acid (Supartz®): a review of its use in osteoarthritis of the knee.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

7.  The role of different hyaluronic acids in the articular cartilage of rabbit.

Authors:  Jaime Antonio Sánchez Lázaro; Pilar Coronel Granado; Mercedes Gimeno Del Sol; Ana González Medina; Luis Díaz Gállego; Daniel González-Arabio Sandoval; Julio Gabriel Prieto Fernández
Journal:  Open Orthop J       Date:  2010-01-19

Review 8.  Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis.

Authors:  Egemen Ayhan; Hayrettin Kesmezacar; Isik Akgun
Journal:  World J Orthop       Date:  2014-07-18

Review 9.  Managing osteoarthritis pain when your patient fails simple analgesics and NSAIDs and is not a candidate for surgery.

Authors:  Mary McHughes; Arthur G Lipman
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

10.  Altered microRNA expression profile in synovial fluid from patients with knee osteoarthritis with treatment of hyaluronic acid.

Authors:  Ji-Feng Xu; Shui-Jun Zhang; Chen Zhao; Bin-Song Qiu; Hai-Feng Gu; Jian-Fei Hong; Li Cao; Yu Chen; Bing Xia; Qin Bi; Ya-Ping Wang
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.